BiotechTube
Home/Hepion Pharmaceuticals/Dr. Kaouthar Lbiati
DK

Dr. Kaouthar Lbiati

Interim Chief Executive Officer

Hepion Pharmaceuticals

Therapeutic Areas

OncologyHepatology

Hepion Pharmaceuticals Pipeline

DrugIndicationPhase
mSEPT9 DNA Biomarker TestEarly Detection & Surveillance of Hepatocellular Carcinoma (HCC) in CirrhosisPre-commercial
ctRNA Biomarker AssayEarly Diagnosis & Surveillance of Hepatocellular Carcinoma (HCC)Assay Development

Leadership Team at Hepion Pharmaceuticals

MP
Michael Purcell
Board Chair
TM
Timothy M. Block, Ph.D.
Director
View full Hepion Pharmaceuticals profile